USFetus Research Consortium
Rubén A. Quintero, M.D. The Fetal Institute, Miami.
Dr. Rubén Quintero completed residency training in Obstetrics and Gynecology and his fellowship in Maternal-Fetal Medicine at Yale University School of Medicine. He is certified by the American Board of Obstetrics and Gynecology in Obstetrics and Gynecology and Maternal-Fetal Medicine.
Dr. Quintero described most of the fetoscopic surgical procedures used today, including the selective laser photocoagulation of communicating vessels (SLPCV) technique to treat twin-to-twin transfusion syndrome (TTTS) and selective intrauterine growth restriction (SIUGR), umbilical cord occlusion for discordant anomalous twins, fetal cystoscopy, direct fetal laryngoscopy, and tracheal occlusion, lysis of amniotic bands, devascularization of type II Vasa Previa and chorioangioma, amniopatch, and the percutaneous fetoscopic approach for the antenatal correction of open spina bifida. He proposed the Quintero Staging System for TTTS and coined the term Selective Intrauterine Growth Restriction (SIUGR). He described the only gestational-age-independent ultrasound index to measure the fetal lung, (Quantitative Lung Index, or QLI). He has designed surgical instruments and patented medical devices specifically for fetal therapy, including the Q-shunt for fetal lower urinary tract obstruction (LUTO).
Dr. Quintero has more than 120 scientific papers, abstracts and book chapters. He is the editor of the first book on minimally invasive fetal surgery, Diagnostic and Operative Fetoscopy, published in 2002, and the editor of the first book on TTTS, Twin-Twin Transfusion Syndrome, published in 2007. He is a member of the Editorial Board of The Journal of Maternal-Fetal and Neonatal Medicine and a peer reviewer for the American Journal of Obstetrics and Gynecology, Obstetrics and Gynecology, British Journal of Obstetrics and Gynecology, Journal of Ultrasound in Obstetrics and Gynecology, the Lancet, Prenatal Diagnosis, Fetal Therapy, among others. Dr. Quintero is founder of the USFetus, a fetal therapy research consortium and co-founder of The Fetal Institute in Miami, FL.